Coen Steven P. sold $3K of DNA
Coen Steven P. (See remarks) sold 307 shares of Ginkgo Bioworks Holdings, Inc. (DNA) at $8.33 on 2026-05-22.
How this was made
The 30-second read
Why it matters
This provides a datapoint on insider behavior but does not include operational, financial, or regulatory developments for the company.
Market read
Traders may briefly adjust sentiment on DNA based on insider selling, but the disclosed transaction is small and not a standalone fundamental catalyst.
What to watch
No 10b5-1 plan is cited, but the filing also lacks intent/valuation context; track whether multiple insiders sell around the same time.
Background
The filing is an SEC Form 4 insider transaction disclosure for Ginkgo Bioworks Holdings, Inc.
Ticker impact
Ginkgo Bioworks officer Coen Steven sold 307 shares in an open-market transaction, disclosing direct holdings and sale price on SEC Form 4.
Likely limited immediate impact; any reaction should fade unless follow-on selling or broader negative catalysts emerge.
This is a routine Form 4 insider transaction without company-specific operational news; size (~$2.6K) is small relative to typical market moves and no 10b5-1 plan is stated.
Market effects
Minimal; single-company Form 4 selling rarely resets biotech/biomanufacturing risk appetite.
None indicated.
None indicated.
Counterpoint
The sale may be for diversification, taxes, or personal liquidity rather than a negative view on fundamentals.
Key entities
- issuerGinkgo Bioworks Holdings, Inc.
Subject of the Form 4 insider sale by officer Coen Steven P.
- insiderCoen Steven P.
Officer who executed an open-market sale of 307 shares at $8.3340 on 2026-05-22.
